- 41% reported high Long COVID symptom interference; older age, female sex, obesity, poorer general, physical and mental health, and U09.9 were associated.
- Within the high interference group, there were no significant associations between symptom interference and having the U09.9 diagnosis code.
- EMR sub-analysis found coding gaps: 64% of high interference participants had a Long COVID-related code, reflecting incomplete capture in records.
BMC Infect Dis. 2026 Jul 7. doi: 10.1186/s12879-026-13943-x. Online ahead of print.
ABSTRACT
PURPOSE: We aimed to test associations of participant-reported Long COVID symptom interference with life activities with Long COVID symptoms, presence of U09.9 Long COVID diagnosis code, demographics, and clinical factors. In a subgroup, we documented coding related to Long COVID and post-exertional malaise in the electronic medical record (EMR).
METHODS: Using a cross-sectional analysis (n = 205) of participant data from a Long COVID survey, we tested associations with Chi-square, Fisher’s exact, or Fisher-Freeman-Halton exact statistical tests and Independent Samples T-tests.
RESULTS: Participants were predominately female (67%) with a mean age of 50.9 years. Participants were White (50.0%), African American (47.5%), and Asian (2.5%); 1.5% reported Hispanic ethnicity. 41% of participants reported high Long COVID symptom interference with life activities. Participants who were older (p=.028), were female (p=.002), were obese (p=.049), had worse general health (p<.001), worse physical health (p<.001), had worse mental health (p<.001), and had U09.9 diagnosis (p<.001) were more likely to experience high symptom interference. Among participants with high symptom interference, there were no significant associations with U09.9 diagnosis code. EMR sub-analysis (n = 100) revealed that among participants that reported high symptom interference (n = 39), 64% (n = 25) had a code related to Long COVID.
CONCLUSION: Although we found discrepancies between self-reported measures and EMR coding, we did not find evidence of demographic biases in diagnosis among participants with high symptom interference.
CLINICAL TRIAL NUMBER: Not applicable.
PMID:42414935 | DOI:10.1186/s12879-026-13943-x
Share Evidence Blueprint

Search Google Scholar
Save as PDF

